Additive/synergistic anti-tumoral effects of the combination of docetaxel and zoledronic acid on prostate cancer cells: Possible mechanisms?

By Ugur Ural A.   Avcu Ferit  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 491-492

Informa Healthcare

Access to resources Recommend Favorite

The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

By Morgan Claire   Lewis Paul D.   Jones Rachel M.   Bertelli Gianfilippo   Thomas Gerry A.   Leonard Robert C. F.  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 669-677

Informa Healthcare

Access to resources Recommend Favorite

Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines

By Epplen Robin   Stöckle Michael   Engelmann Udo   Heidenreich Axel   Ohlmann Carsten-Henning  

Acta Oncologica, Vol. 50, Iss. 1, 2011-01 ,pp. : 127-133

Informa Healthcare

Access to resources Recommend Favorite

Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines

By                

International Journal of Oncology, Vol. 42, Iss. 4, 2013-01 ,pp. : 1263-1270

Spandidos Publications

Access to resources Recommend Favorite

Effects of D-allose in combination with docetaxel in human head and neck cancer cells

By              

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2044-2050

Spandidos Publications

Access to resources Recommend Favorite